These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12401956)

  • 1. Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice.
    LeVine SM; Maiti S; Emerson MR; Pedchenko TV
    Dev Neurosci; 2002; 24(2-3):177-83. PubMed ID: 12401956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis.
    Forge JK; Pedchenko TV; LeVine SM
    Life Sci; 1998; 63(25):2271-84. PubMed ID: 9870713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis.
    Chakrabarty A; Emerson MR; LeVine SM
    Mult Scler; 2003 Aug; 9(4):372-81. PubMed ID: 12926842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis.
    Ćurko-Cofek B; Kezele TG; Marinić J; Tota M; Čizmarević NS; Milin Č; Ristić S; Radošević-Stašić B; Barac-Latas V
    Neurotoxicology; 2016 Dec; 57():1-12. PubMed ID: 27570231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxic potential of exogenous ferritin and apoferritin: changes in ambient level of glutamate and synaptic vesicle acidification in brain nerve terminals.
    Krisanova N; Sivko R; Kasatkina L; Borуsov A; Borisova T
    Mol Cell Neurosci; 2014 Jan; 58():95-104. PubMed ID: 24321453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis.
    LeVine SM; Chakrabarty A
    Ann N Y Acad Sci; 2004 Mar; 1012():252-66. PubMed ID: 15105271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
    Bill R; Döring A; Deutsch U; Engelhardt B
    J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability.
    Garner B; Li W; Roberg K; Brunk UT
    Free Radic Res; 1997 Nov; 27(5):487-500. PubMed ID: 9518065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Zhang Z; Schittenhelm J; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):231-40. PubMed ID: 17983427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis.
    Dunham J; Bauer J; Campbell GR; Mahad DJ; van Driel N; van der Pol SMA; 't Hart BA; Lassmann H; Laman JD; van Horssen J; Kap YS
    J Neuropathol Exp Neurol; 2017 Jun; 76(6):467-478. PubMed ID: 28505283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin inhibition in experimental autoimmune encephalomyelitis.
    Beilin O; Karussis DM; Korczyn AD; Gurwitz D; Aronovich R; Hantai D; Grigoriadis N; Mizrachi-Kol R; Chapman J
    J Neurosci Res; 2005 Feb; 79(3):351-9. PubMed ID: 15605378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferritin- and apoferritin-induced immune complex glomerulonephritis in mice.
    Hagstrom GL; Bloom PM; Yum MN; Lavelle KJ; Luft FC
    Nephron; 1979; 24(3):127-33. PubMed ID: 492422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.
    Mitchell KM; Dotson AL; Cool KM; Chakrabarty A; Benedict SH; LeVine SM
    Mult Scler; 2007 Nov; 13(9):1118-26. PubMed ID: 17967839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
    Sands SA; Tsau S; LeVine SM
    Neurosci Lett; 2015 Oct; 606():204-8. PubMed ID: 26362814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceruloplasmin gene-deficient mice with experimental autoimmune encephalomyelitis show attenuated early disease evolution.
    Gresle MM; Schulz K; Jonas A; Perreau VM; Cipriani T; Baxter AG; Miranda-Hernandez S; Field J; Jokubaitis VG; Cherny R; Volitakis I; David S; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2014 Jun; 92(6):732-42. PubMed ID: 24615902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.
    Kizelsztein P; Komarnytsky S; Raskin I
    J Neuroimmunol; 2009 Dec; 217(1-2):28-37. PubMed ID: 19796825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
    Harris VK; Donelan N; Yan QJ; Clark K; Touray A; Rammal M; Sadiq SA
    Mult Scler; 2013 Oct; 19(11):1462-72. PubMed ID: 23439582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.